Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

291 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study.
Scheithauer W, Kornek G, Marczell A, Salem G, Karner J, Kovats E, Burger D, Greiner R, Pidlich J, Schneeweiss B, Raderer M, Rosen H, Depisch D. Scheithauer W, et al. J Clin Oncol. 1997 Mar;15(3):908-14. doi: 10.1200/JCO.1997.15.3.908. J Clin Oncol. 1997. PMID: 9060527 Clinical Trial.
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group.
Wils J, Sahmoud T, Sobrero A, Bleiberg H, Ahmedzai S, Blazeby J, Blijham G, Conroy T, Cunningham D, Curran D, Díaz-Rubio E, Ducreux M, Evans J, Glimelius B, Hutchinson G, Kerr D, Kiebert G, Köhne H, Labianca R, Langendijk R, Nitti D, Nordlinger B, Rougier P, Scheithauer W, Therasse P, et al. Wils J, et al. Among authors: scheithauer w. Tumori. 1998 May-Jun;84(3):335-47. doi: 10.1177/030089169808400306. Tumori. 1998. PMID: 9678614
5-methyltetrahydrofolate for biochemical modulation of fluorouracil (FU) in patients with advanced colorectal cancer: a randomized phase I-II study of two different FU administration schedules.
Hejna M, Kornek GV, Raderer M, Valencak J, Weinländer G, Fiebiger W, Miholic J, Scheithauer W. Hejna M, et al. Among authors: scheithauer w. Ann Oncol. 1998 Dec;9(12):1309-14. doi: 10.1023/a:1008448214105. Ann Oncol. 1998. PMID: 9932161 Free article. Clinical Trial.
Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy.
Ulrich-Pur H, Kornek GV, Fiebiger W, Gedlicka C, Raderer M, Lenauer A, Depisch D, Lang F, Pidlich J, Scheithauer W. Ulrich-Pur H, et al. Among authors: scheithauer w. Ann Oncol. 2001 Sep;12(9):1269-72. doi: 10.1023/a:1012240201462. Ann Oncol. 2001. PMID: 11697839 Free article. Clinical Trial.
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients.
Köhne CH, Cunningham D, Di Costanzo F, Glimelius B, Blijham G, Aranda E, Scheithauer W, Rougier P, Palmer M, Wils J, Baron B, Pignatti F, Schöffski P, Micheel S, Hecker H. Köhne CH, et al. Among authors: scheithauer w. Ann Oncol. 2002 Feb;13(2):308-17. doi: 10.1093/annonc/mdf034. Ann Oncol. 2002. PMID: 11886010 Free article. Clinical Trial.
291 results